141 related articles for article (PubMed ID: 10220441)
1. A first-generation packaging cell line for Epstein-Barr virus-derived vectors.
Delecluse HJ; Pich D; Hilsendegen T; Baum C; Hammerschmidt W
Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5188-93. PubMed ID: 10220441
[TBL] [Abstract][Full Text] [Related]
2. Genetic design of an optimized packaging cell line for gene vectors transducing human B cells.
Hettich E; Janz A; Zeidler R; Pich D; Hellebrand E; Weissflog B; Moosmann A; Hammerschmidt W
Gene Ther; 2006 May; 13(10):844-56. PubMed ID: 16421600
[TBL] [Abstract][Full Text] [Related]
3. High level of transgene expression in primary chronic lymphocytic leukemia cells using helper-virus-free recombinant Epstein-Barr virus vectors.
Wendtner CM; Kurzeder C; Theiss HD; Kofler DM; Baumert J; Delecluse HJ; Janz A; Hammerschmidt W; Hallek M
Exp Hematol; 2003 Feb; 31(2):99-108. PubMed ID: 12591274
[TBL] [Abstract][Full Text] [Related]
4. Infectious delivery of 120-kilobase genomic DNA by an epstein-barr virus amplicon vector.
White RE; Wade-Martins R; James MR
Mol Ther; 2002 Apr; 5(4):427-35. PubMed ID: 11945070
[TBL] [Abstract][Full Text] [Related]
5. Development of a novel helper-dependent adenovirus-Epstein-Barr virus hybrid system for the stable transformation of mammalian cells.
Dorigo O; Gil JS; Gallaher SD; Tan BT; Castro MG; Lowenstein PR; Calos MP; Berk AJ
J Virol; 2004 Jun; 78(12):6556-66. PubMed ID: 15163748
[TBL] [Abstract][Full Text] [Related]
6. The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy.
Delecluse HJ; Hammerschmidt W
Mol Pathol; 2000 Oct; 53(5):270-9. PubMed ID: 11091851
[TBL] [Abstract][Full Text] [Related]
7. Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.
Delecluse HJ; Feederle R; Behrends U; Mautner J
Semin Cancer Biol; 2008 Dec; 18(6):409-15. PubMed ID: 18938248
[TBL] [Abstract][Full Text] [Related]
8. Development of a competitive PCR method for physical titration of recombinant EBV vector in a helper-dependent packaging system.
Wang J; Vos JM
Mol Ther; 2001 Jun; 3(6):976-83. PubMed ID: 11407912
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic gene delivery in human B-lymphoblastoid cells by engineered non-transforming infectious Epstein-Barr virus.
Banerjee S; Livanos E; Vos JM
Nat Med; 1995 Dec; 1(12):1303-8. PubMed ID: 7489413
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus type 2 lentivirus vectors for gene transfer: expression and potential for helper virus-free packaging.
Arya SK; Zamani M; Kundra P
Hum Gene Ther; 1998 Jun; 9(9):1371-80. PubMed ID: 9650621
[TBL] [Abstract][Full Text] [Related]
11. Simian virus 40 (SV40) large T antigen-dependent amplification of an Epstein-Barr virus-SV40 hybrid shuttle vector integrated into the human HeLa cell genome.
Stary A; Sarasin A
J Gen Virol; 1992 Jul; 73 ( Pt 7)():1679-85. PubMed ID: 1321208
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus vectors for gene delivery to B lymphocytes.
Robertson ES; Ooka T; Kieff ED
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11334-40. PubMed ID: 8876136
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy strategies for treating Epstein-Barr virus-associated lymphomas: comparison of two different Epstein-Barr virus-based vectors.
Kenney S; Ge JQ; Westphal EM; Olsen J
Hum Gene Ther; 1998 May; 9(8):1131-41. PubMed ID: 9625252
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetic analysis of herpesviruses and their potential use as vectors for gene therapy applications.
Cotter MA; Robertson ES
Curr Opin Mol Ther; 1999 Oct; 1(5):633-44. PubMed ID: 11249670
[TBL] [Abstract][Full Text] [Related]
15. Engineering a mini-herpesvirus as a general strategy to transduce up to 180 kb of functional self-replicating human mini-chromosomes.
Sun TQ; Livanos E; Vos JM
Gene Ther; 1996 Dec; 3(12):1081-8. PubMed ID: 8986434
[TBL] [Abstract][Full Text] [Related]
16. A novel herpesvirus amplicon system for in vivo gene delivery.
Wang S; Di S; Young WB; Jacobson C; Link CJ
Gene Ther; 1997 Nov; 4(11):1132-41. PubMed ID: 9425435
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-derived vectors for transient and stable expression of recombinant proteins.
Cachianes G; Ho C; Weber RF; Williams SR; Goeddel DV; Leung DW
Biotechniques; 1993 Aug; 15(2):255-9. PubMed ID: 8396947
[TBL] [Abstract][Full Text] [Related]
18. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.
Hammerschmidt W; Sugden B
Nature; 1989 Aug; 340(6232):393-7. PubMed ID: 2547164
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus vector-mediated gene transfer into human B cells: potential for antitumor vaccination.
Hellebrand E; Mautner J; Reisbach G; Nimmerjahn F; Hallek M; Mocikat R; Hammerschmidt W
Gene Ther; 2006 Jan; 13(2):150-62. PubMed ID: 16136164
[TBL] [Abstract][Full Text] [Related]
20. Hybrid herpes simplex virus/Epstein-Barr virus amplicon viral vectors confer enhanced transgene expression in primary human tumors and human bone marrow-derived mesenchymal stem cells.
Sia KC; Chong WK; Ho IA; Yulyana Y; Endaya B; Huynh H; Lam PY
J Gene Med; 2010 Oct; 12(10):848-58. PubMed ID: 20963807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
